Skip to Content Facebook Feature Image

Nipro Announces Major Expansion with New Medical Device Manufacturing Facility in Greenville, North Carolina, USA

Business

Nipro Announces Major Expansion with New Medical Device Manufacturing Facility in Greenville, North Carolina, USA
Business

Business

Nipro Announces Major Expansion with New Medical Device Manufacturing Facility in Greenville, North Carolina, USA

2024-07-18 05:00 Last Updated At:05:15

GREENVILLE, N.C., July 18, 2024 /PRNewswire/ -- Nipro Medical Corporation, a leader in the global healthcare and medical device industry, proudly announces its significant expansion in the United States with the establishment of its first North American manufacturing facility in Greenville, North Carolina. This strategic development is set to generate 232 new jobs and involve an investment of approximately $398 million over the next five years.

Governor Roy Cooper Welcomes Nipro to North Carolina
Governor Roy Cooper expressed his enthusiasm about Nipro's decision to expand to North Carolina, highlighting the state's reputation as a center for advanced manufacturing. "We are delighted to welcome Nipro to North Carolina," Governor Cooper stated. "This initiative not only reinforces our status as a prime location for advanced manufacturing but also demonstrates our state's capability in providing a skilled workforce and a superior quality of life."

Nipro to Enhance Local Production and Job Creation
Founded in Japan, Nipro stands as a Tier 1 manufacturer renowned for its high-quality medical devices and healthcare solutions. Tsuyoshi Yamazaki, Senior Managing Director of Global Business at Nipro, shared his excitement about the new facility. "We are thrilled to start manufacturing our cutting-edge medical devices in the U.S., which will support local healthcare professionals and patients with a stable supply chain and reduced transportation costs," said Yamazaki. "Our close proximity to customers will allow us to better respond to their needs and provide them with timely and effective solutions."

This investment highlights Nipro's commitment to innovation, growth, and environmental sustainability.

By establishing manufacturing in the United States, Nipro will significantly reduce global transportation needs, cutting down on carbon emissions. This initiative underscores Nipro's dedication to minimizing environmental impact and fostering a sustainable future. "Our new facility in Greenville is a major milestone in our sustainability journey, reflecting our commitment to reducing our carbon footprint," said Mr. Yamazaki. Nipro continues to lead by example in the medical device industry, championing environmental stewardship and sustainable practices.

A Testament to International Commitment
Akira Shimizu, CEO of Nipro Medical Corporation, reflected on the significant impact of this expansion. "This new facility marks a major milestone in Nipro's commitment to the U.S. market, allowing us to deliver high-quality medical devices that enhance patient outcomes and quality of life across the country," said Shimizu.

Significant Economic Impact and Job Opportunities
The new facility in Pitt County marks Nipro's first venture into producing advanced medical devices directly in the U.S. market. The advanced manufacturing site will host a range of positions from engineering and production to administrative and management roles. Nipro values ownership, flexibility, and team spirit among its employees. People who are willing to make a difference and contribute to Nipro's mission are welcome to join and grow with the company.

North Carolina: A Hub for STEM and Manufacturing Talent
N.C. Commerce Secretary Machelle Baker Sanders noted, "North Carolina's rich environment for STEM talent and our robust manufacturing workforce make it an ideal location for global healthcare leaders like Nipro. Our commitment to fostering growth ensures that North Carolina remains at the forefront of medical innovation and manufacturing."

Supporting Patients with Diabetes and Chronic Kidney Disease
The North Carolina facility is set to produce state-of-the-art medical devices that support patients with diabetes, chronic kidney disease, and other renal health issues, reflecting Nipro's commitment to enhancing the quality of patient care through innovative medical technologies.

Vice President of Manufacturing Operations and Inaugural Site Leader for the Greenville Medical Device Plant Anticipates Collaboration and Success
Krizay Elenitoba-Johnson, Vice President of Manufacturing Operations and Inaugural Site Leader for the Greenville Medical Device Plant, expressed anticipation for the collaborative opportunities ahead. "I look forward to working with our dedicated team and the supportive community here to achieve great successes," Elenitoba-Johnson remarked.

Nipro Medical Corporation (https://www.nipro.com [nipro.com]), headquartered in Bridgewater, is a wholly-owned subsidiary of Nipro Corporation, headquartered in Osaka, Japan. Established in 1954, our parent company employs more than 38,000+ team members and specializes in medical, pharmaceutical, and glass products. Nipro Corporation is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Nipro Announces Major Expansion with New Medical Device Manufacturing Facility in Greenville, North Carolina, USA

Nipro Announces Major Expansion with New Medical Device Manufacturing Facility in Greenville, North Carolina, USA

IN PARTNERSHIP WITH ARTHOUSE/ABBEY ROAD INSTITUTE, SINCE THE PROGRAM'S START IN 2022, ACHIEVES THESE CONSECUTIVE WINS

THIS UNIQUE ALLIANCE IS REDEFINING ARTIST DEVELOPMENT BY COMBINING EDUCATION, MENTORSHIP, AND PROFESSIONAL DEVELOPMENT TO ACHIEVE MUSICAL EXCELLENCE

IN 2023 SINGER-SONGWRITER JOAQUINA STARTED THIS QUEST AND IN 2024 ELA TAUBERT CONTINUES THE JOURNEY ACHIEVING THIS UNPARALLELED CONSECUTIVE WIN

"To witness the growth of these new female artists, to experience how they have worked these years on their artistic development being exceptional students and to see that the music that they share is recognized by the Latin Recording Academy is of great fulfillment for our teams at Universal Music and Art House." – 
Jesus Lopez,  Charmain & CEO Universal Music Latinoamérica and Iberia Península

"Artists have a mission to capture their version of beauty in its purest state, free of all industry expectations and trends. We are protecting and accompanying artists in the process, because it is the only way to create long-lived artists and art that will positively transform the societies of the future. An artist today is more than a brand or a collection of songs. An artist today is a spiritual guide, a refuge, a temple where the answers that sometimes reason cannot find live." – Julio Reyes, Founder of Arthouse Abbey Road Academy Miami

MIAMI, Nov. 17, 2024 /PRNewswire/ -- In an unprecedented and extraordinary showcase combining education, artist development and musical excellence, Universal Music Latino and Arthouse achieves back-to-back wins in the prestigious Best New Artist category at the Latin GRAMMY Award for two consecutive years. Following the victory of Venezuelan singer-songwriter Joaquina, who made headlines as the youngest-ever recipient of this award in 2023, and now Colombian pop sensation Ela Taubert, marking a significant milestone for both Universal Music Latino and Arthouse.

The partnership between Universal Music Latino and Arthouse is a beacon of innovation and collaboration, merging education, musical excellence, development, and talent to create a global platform for emerging artist. This collaboration is rooted in a shared vision of empowering artists through comprehensive support systems, including mentorship programs, professional development, and resources tailored to enhance their artistic growth. By emphasizing the importance of education in the creative process, the partnership is paving the way for a new generation of Latin music stars globally.

Besides, Joaquina and Ela Taubert other notable artist include: Paola Guanche, Latin GRAMMY Nominee 2023, Maura Nava, Latin GRAMMY Nominee 2024, Riza, Jules, Fabian, and Ana Sofia.

As the Latin music landscape continues to change, Universal Music Latino and Arthouse remain at the forefront, championing new talent and redefining the industry standards. The back-to-back successes in the Best New Artist category underscore the dedication to innovation, education, and the relentless pursuit of excellence. 

About Universal Music Group

At Universal Music Group, we exist to shape culture through the power of artistry. UMG is the world leader in music-based entertainment, with a broad array of businesses engaged in recorded music, music publishing, merchandising and audio-visual content. Featuring the most comprehensive catalogue of recordings and songs across every musical genre, UMG identifies and develops artists and produces and distributes the most critically acclaimed and commercially successful music in the world. Committed to artistry, innovation and entrepreneurship, UMG fosters the development of services, platforms and business models in order to broaden artistic and commercial opportunities for our artists and create new experiences for fans. For more information on Universal Music Group visit www.universalmusic.com

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

UNIVERSAL MUSIC LATINO ACHIEVES HISTORIC BACK-TO-BACK LATIN GRAMMY BEST NEW ARTIST WINS CONFIRMING TO BE THE HOME OF ARTIST DEVELOPMENT

UNIVERSAL MUSIC LATINO ACHIEVES HISTORIC BACK-TO-BACK LATIN GRAMMY BEST NEW ARTIST WINS CONFIRMING TO BE THE HOME OF ARTIST DEVELOPMENT

Recommended Articles